<p>Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date</p>

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Francesco Facchinetti, Luc Friboulet

Journal title: Lung Cancer: Targets and Therapy

Journal number: Volume 10

Journal publisher: Dove Medical Press Ltd

Published year: 2019

Published pages: 87-94

DOI identifier: 10.2147/lctt.s190786

ISSN: 1179-2728